Skip to main content
Premium Trial:

Request an Annual Quote

Exiqon to Use MultiD Data-Analysis Software in miRNA qPCR Platform


Danish microRNA company Exiqon said today that it has signed a development and distribution agreement with MultiD Analyses in the area of qPCR data analysis.

Under the agreement, the companies will incorporate a version of MultiD's GenEx qPCR analysis software into Exiqon's MiRcury Locked Nucleic Acid Universal RT microRNA PCR system, enabling Exiqon to offer a fully compatible and comprehensive data-analysis tool with its system.

The GenEx software has been adapted to allow "easy pre-processing and analysis of data from the Exiqon miRNA PCR panels and assays," Henrik Pfundheller, vice president of sales and marketing for Exiqon, said in a statement.

Pfundheller added that it is important that Exiqon's customers can "process, normalize, and analyze their qPCR data properly and with confidence."

Specifically, MultiD has developed a special plate design module for its software that will enable Exiqon customers to design qPCR experiments in silico and generate templates for import into their real-time PCR instruments, Mikael Kubista, chairman of MultiD, said in a statement.

The GenEx software includes features such as reference gene selection and validation, data pre-processing, and advanced statistical methods to process and analyze qPCR data.

Exiqon's miRcury LNA Universal RT microRNA PCR system uses two LNA-enhanced PCR primers that enable accurate quantification of very low miRNA levels and discrimination between closely related miRNA sequences, Exiqon said.

The product line includes miRNA ready-to-use PCR panels to conduct expression profiling of 730 human miRNAs, individual miRNA assays, reference genes, and reagent kits.

Earlier this month, Exiqon inked a deal with BioDiscovery giving Exiqon the right to include BioDiscovery's array image analysis, data analysis, and visualization software with Exiqon's miRNA arrays.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.